Areys Biosciences

Areys Bio is a biotechnology company dedicated to expanding the reach of RNA therapeutics beyond the liver. Founded by pioneers in the RNA interference (RNAi) field, the company utilizes its proprietary Areys platform to achieve precise, area-specific delivery of RNA-based medicines to extrahepatic tissues. The platform is designed to target tissues such as the central nervous system and muscle, which have historically been difficult to reach with systemic RNA delivery. By overcoming these delivery challenges, Areys Bio aims to develop transformative treatments for a wide range of debilitating diseases with high unmet medical needs. The company is currently in the pre-clinical stage, focusing on optimizing its delivery technology and building a robust internal pipeline of siRNA candidates.